$OPK Exiting times in biotech and the Corona virus play. At this moment, OPK with its innovative drive thru testing in NY by it’s lab, BioReference and the big news that will soon with its HGH joint agreement with Pfizer when OPK receives a $275 Million up front royalty payment from PFE is a very exiting company. Buying more OPK!
  • 6

    Get The Stocktwits Daily Rip

    ©2020 StockTwits, Inc. All rights reserved.
    Market Data by Xignite and BATS BZX Real-Time Price

    Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc.
    Investing in securities products involves risk, including possible loss of principal.
    Please read important legal disclosures.